Increase in Livestock Population and Repeated Breakouts of Livestock Diseases, Increasing Incidence Of Zoonotic Diseases, Initiatives By Various Government Agencies, Animal Associations, And Leading Players, And The Introduction Of New Vaccine Types To Drive the Growth of Veterinary Vaccine Market
In this market, primary investment opportunities are in emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India; these are lucrative markets for veterinary vaccines, owing to favorable government initiatives.
The global veterinary vaccines market is poised to reach USD 7.68 billion by 2021 from USD 5.81 billion in 2016, at a CAGR of 5.8% from 2016 to 2021.
The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and region. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. In this market, companion animal vaccines form the fastest-growing product segment, due to the increasing number of zoonotic diseases in the human population and the growing number of pet owners worldwide.
The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to account for the highest growth of the veterinary vaccines market in 2016, due to innovations in technology and increased public awareness about animal vaccination.
New and innovative product launches and collaboration were the dominant strategies adopted by companies in this market.
This research report focuses on qualitative data, market size, and the growth of various segments and sub segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and government initiatives. The competitive landscape covers growth strategies adopted by industry players in the last three years. Company profiles comprise basic views on key players in the veterinary vaccines market and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the veterinary vaccines market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on products offered by top players in the veterinary vaccines market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the veterinary vaccines market
- Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for veterinary vaccines across various regions
- Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the veterinary vaccines market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and the manufacturing capabilities of leading players in the veterinary vaccines market